Roy R. Teller

Array ( [id] => 11031597 [patent_doc_number] => 20160228553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'Stabilised Solid Compositions of Factor VII Polypeptides' [patent_app_type] => utility [patent_app_number] => 15/133654 [patent_app_country] => US [patent_app_date] => 2016-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15573 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15133654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11479419 [patent_doc_number] => 09585941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Eye drop formulation' [patent_app_type] => utility [patent_app_number] => 15/000297 [patent_app_country] => US [patent_app_date] => 2016-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10687 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15000297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10743266 [patent_doc_number] => 20160089417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-31 [patent_title] => 'TREATING LIVER DISEASES' [patent_app_type] => utility [patent_app_number] => 14/924032 [patent_app_country] => US [patent_app_date] => 2015-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9504 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14924032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10676616 [patent_doc_number] => 20160022762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'Agent for Eliminating Multidrug Resistance' [patent_app_type] => utility [patent_app_number] => 14/853529 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6933 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10750715 [patent_doc_number] => 20160096866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'POTENT COMPSTATIN ANALOGS' [patent_app_type] => utility [patent_app_number] => 14/850686 [patent_app_country] => US [patent_app_date] => 2015-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14446 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14850686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10458049 [patent_doc_number] => 20150343064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'Stabilised Solid Compositions of Factor VII Polypeptides' [patent_app_type] => utility [patent_app_number] => 14/823573 [patent_app_country] => US [patent_app_date] => 2015-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15557 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14823573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10669627 [patent_doc_number] => 20160015772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME' [patent_app_type] => utility [patent_app_number] => 14/801303 [patent_app_country] => US [patent_app_date] => 2015-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19617 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14801303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11684982 [patent_doc_number] => 09683017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-20 [patent_title] => 'Inhibitory peptides of viral infection' [patent_app_type] => utility [patent_app_number] => 14/801717 [patent_app_country] => US [patent_app_date] => 2015-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19585 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14801717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10458006 [patent_doc_number] => 20150343021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'METHODS FOR TREATING CANCER USING COMPOSITIONS COMPRISING HSS1 AND/OR HSM1' [patent_app_type] => utility [patent_app_number] => 14/726247 [patent_app_country] => US [patent_app_date] => 2015-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18033 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14726247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11575746 [patent_doc_number] => 09630993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'HER2Delta16 peptides' [patent_app_type] => utility [patent_app_number] => 14/712165 [patent_app_country] => US [patent_app_date] => 2015-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12702 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14712165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405320 [patent_doc_number] => 20150290329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'Hetero-assembling, Tunable, and Injectable Hydrogels for Cell Encapsulation' [patent_app_type] => utility [patent_app_number] => 14/690589 [patent_app_country] => US [patent_app_date] => 2015-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23376 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14690589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10373173 [patent_doc_number] => 20150258179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'TREATING LIVER DISEASES' [patent_app_type] => utility [patent_app_number] => 14/665559 [patent_app_country] => US [patent_app_date] => 2015-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9479 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14665559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10641420 [patent_doc_number] => 09358271 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-07 [patent_title] => 'Use of natriuretic peptide for treating heart failure' [patent_app_type] => utility [patent_app_number] => 14/632350 [patent_app_country] => US [patent_app_date] => 2015-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 24 [patent_no_of_words] => 16268 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14632350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10340456 [patent_doc_number] => 20150225461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'CRYSTALLINE AND AMORPHOUS FORMS OF A BETA-ARRESTIN EFFECTOR' [patent_app_type] => utility [patent_app_number] => 14/616487 [patent_app_country] => US [patent_app_date] => 2015-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18437 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14616487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9858435 [patent_doc_number] => 20150038453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'PREPARATION FOR USE OF ASPARTATE AND VITAMIN B12 OR BIOTIN FOR REGULATING KETONE BODIES' [patent_app_type] => utility [patent_app_number] => 14/516129 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15337 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14516129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408933 [patent_doc_number] => 09556225 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Peptide stimulator of cell survival and proliferation' [patent_app_type] => utility [patent_app_number] => 14/515279 [patent_app_country] => US [patent_app_date] => 2014-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 6637 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10388004 [patent_doc_number] => 20150273011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 14/512250 [patent_app_country] => US [patent_app_date] => 2014-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5181 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14512250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10317311 [patent_doc_number] => 20150202315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'CANCER TARGETING PEPTIDES FOR ENHANCING ANTI-CANCER DRUG DELIVERY AND THERAPEUTIC EFFICENCIES' [patent_app_type] => utility [patent_app_number] => 14/499201 [patent_app_country] => US [patent_app_date] => 2014-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12263 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14499201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10311571 [patent_doc_number] => 20150196573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'PROCESS FOR PRODUCING AN INJECTABLE MEDICAMENT PREPARATION' [patent_app_type] => utility [patent_app_number] => 14/469232 [patent_app_country] => US [patent_app_date] => 2014-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7081 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14469232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10946903 [patent_doc_number] => 20140349925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'NOVEL INSULIN DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/453276 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18576 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14453276 [rel_patent_id] =>[rel_patent_doc_number] =>)